Imidazoline Receptors

Imidazoline binding sites were originally classified into I1 sites (labeled by clonidine) and I2 sites (labeled by idazoxan). I2 sites have been further classified into I2A (amiloride-sensitive) and I2B (amiloride-insensitive). A putative I3 has been described which enhances insulin secretion.

Imidazoline Receptor Target Files

Related Categories

Imidazoline receptors have a physiological role in the central regulation of blood pressure. Activation of I1 receptors decreases sympathetic tone via a central mechanism, which has a hypotensive effect and reduces plasma catecholamine levels. In contrast, I2-mediated monoamine oxidase inhibition has a hypertensive effect and increases plasma catecholamine levels.

Receptor I1 I2 I3
Location Lateral reticular nucleus, locus ceruleus, kidney, platelets, pancreas Interpeduncular and arcuate nuclei, pineal gland, liver, kidney, heart, striated muscle, MAO Pancreatic β cells
Transduction Mechanism ↑ Diacylglycerol and arachidonic acid Unknown Unknown
Key Selective Ligands AGN 192403 (1072)
Clonidine (0690)
Rilmenidine (0790)
BU 239 (0726)
RS 45041-190 (0889)
2-BFI (0348)
KU14R (1131)
Putative Endogenous Ligands Agmatine (0842), Harmane (1132)

Quick Order

Find multiple products by catalog number

divider line

New Product Guide

New Product Guide (Fall/Winter 2016)

Our New Product guide highlights over 100 new products added in the second half of 2016. Request copy or view PDF today.

divider line

LinkedIn Updates

Follow Tocris on LinkedIn

Follow us on LinkedIn!

Visit our LinkedIn page for the latest Tocris news, events and updates.